Abnormalities of the somatotrophic axis in the obese agouti mouse

[1]  N. Martin,et al.  Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY3–36 but resistant to ghrelin , 2004, International Journal of Obesity.

[2]  T. Horvath,et al.  Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  H. Watanobe,et al.  Evaluation of the Role of Melanocortin 3 and 4 Receptors in Leptin-Stimulated and Spontaneous Growth Hormone Secretion in Rats , 2003, Neuroendocrinology.

[4]  A. Grüters,et al.  Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. , 2003, The Journal of clinical endocrinology and metabolism.

[5]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[6]  I. Robinson,et al.  Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones , 2003, The Journal of physiology.

[7]  Tim Cheetham,et al.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. , 2003, The New England journal of medicine.

[8]  M. Aubert,et al.  The Melanocortin Agonist Melanotan‐II Reduces the Orexigenic and Adipogenic Effects of Neuropeptide Y (NPY) but Does not Affect the NPY‐Driven Suppressive Effects on the Gonadotropic and Somatotropic Axes in the Male Rat , 2003, Journal of neuroendocrinology.

[9]  S. Bloom,et al.  The Hypothalamic Mechanisms of the Hypophysiotropic Action of Ghrelin , 2002, Neuroendocrinology.

[10]  B. Levin,et al.  Reduced central leptin sensitivity in rats with diet-induced obesity. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  M. Phillip,et al.  Leptin Acts as a Growth Factor on the Chondrocytes of Skeletal Growth Centers , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  H. Yoshimatsu,et al.  Hyperleptinemia in A(y)/a mice upregulates arcuate cocaine- and amphetamine-regulated transcript expression. , 2002, American journal of physiology. Endocrinology and metabolism.

[13]  A. Mark,et al.  The concept of selective leptin resistance: evidence from agouti yellow obese mice. , 2002, Diabetes.

[14]  T. Pedrazzini,et al.  Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism , 2001, Molecular and Cellular Endocrinology.

[15]  G. Frost,et al.  Ghrelin enhances appetite and increases food intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[16]  T. Wells,et al.  Skeletal Growth Acceleration with Growth Hormone Secretagogues in Transgenic Growth Retarded Rats: Pattern‐Dependent Effects and Mechanisms of Desensitization , 2001, Journal of neuroendocrinology.

[17]  E. Ravussin,et al.  Circulating ghrelin levels are decreased in human obesity. , 2001, Diabetes.

[18]  S. Yakar,et al.  The somatomedin hypothesis: 2001. , 2001, Endocrine reviews.

[19]  M. Aubert,et al.  Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes. , 2000, Endocrinology.

[20]  S. Bloom,et al.  The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. , 2000, Endocrinology.

[21]  Yue Feng,et al.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.

[22]  R. Cone,et al.  A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse. , 2000, Endocrinology.

[23]  C. Steppan,et al.  Leptin is a potent stimulator of bone growth in ob/ob mice , 2000, Regulatory Peptides.

[24]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[25]  S. O’Rahilly,et al.  Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. , 2000, The Journal of clinical investigation.

[26]  G. Barsh,et al.  Anatomy of an Endogenous Antagonist: Relationship between Agouti-Related Protein and Proopiomelanocortin in Brain , 1999, The Journal of Neuroscience.

[27]  L. Yaswen,et al.  Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin , 1999, Nature Medicine.

[28]  Navarra,et al.  The Effect of Growth Hormone Secretagogues and Neuropeptide Y on Hypothalamic Hormone Release from Acute Rat Hypothalamic Explants , 1999, Journal of neuroendocrinology.

[29]  W. J. Visek,et al.  Caloric restriction abolishes enhanced metabolic efficiency induced by ectopic agouti protein in yellow mice. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[30]  F. Casanueva,et al.  Role of Growth Hormone (GH)-Releasing Hormone and Somatostatin on Leptin-Induced GH Secretion , 1999, Neuroendocrinology.

[31]  T. Hökfelt,et al.  Hypocretin/Orexin‐ and melanin‐concentrating hormone‐expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene‐related protein systems , 1998, The Journal of comparative neurology.

[32]  L. Vanhaelst,et al.  Cafeteria diet-induced obesity is associated with a low spontaneous growth hormone secretion and normal plasma insulin-like growth factor-I concentrations. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[33]  S. Bloom,et al.  A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. , 1998, Endocrinology.

[34]  Michael W. Schwartz,et al.  Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons , 1998, Nature Neuroscience.

[35]  J. Shutter,et al.  Overexpression of Agrt leads to obesity in transgenic mice , 1997, Nature Genetics.

[36]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[37]  R. Cone,et al.  Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. , 1997, Molecular endocrinology.

[38]  E. Hooghe-Peters,et al.  Cafeteria diet-induced obese rats have an increased somatostatin protein content and gene expression in the periventricular nucleus , 1997, Journal of endocrinological investigation.

[39]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[40]  R. Palmiter,et al.  Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.

[41]  D. Smith,et al.  Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on alpha-TSH cells. , 1996, Endocrinology.

[42]  S. Woods,et al.  Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob Mice , 1996, Diabetes.

[43]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[44]  I. Robinson,et al.  Hypothalamic GH receptor gene expression in the rat: effects of altered GH status. , 1995, The Journal of endocrinology.

[45]  Richard P. Woychik,et al.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.

[46]  M. Mortrud,et al.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. , 1994, Molecular endocrinology.

[47]  C. Deal,et al.  Hormonal control of growth in the genetically obese Zucker rat. I. Linear growth, plasma insulin-like growth factor-I (IGF-I) and IGF-binding proteins. , 1994, Endocrinology.

[48]  I. Robinson,et al.  Growth hormone binding protein in the rat: effects of gonadal steroids. , 1993, Endocrinology.

[49]  S. Mccann,et al.  Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. , 1990, Endocrinology.

[50]  J. Ilan,et al.  Expression of insulin-like growth factor I in cultured rat hepatocytes: effects of insulin and growth hormone. , 1989, Molecular endocrinology.

[51]  V. Mendel.  Influence of the insulin-to-growth hormone ratio on body composition of mice. , 1980, The American journal of physiology.

[52]  Yen Tt,et al.  An analysis of the relationships among obesity, plasma insulin, and hepatic lipogenic enzymes in 'viable yellow obese' mice (avy/a). , 1976 .

[53]  W. E. Heston,et al.  Influence of the Ay gene on mammary-gland tumors, hepatomas, and normal growth in mice. , 1961, Journal of the National Cancer Institute.

[54]  E. Müller,et al.  Neuroendocrine control of growth hormone secretion , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[55]  S. O’Rahilly,et al.  Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. , 2003, The Journal of clinical endocrinology and metabolism.

[56]  R. Cone,et al.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. , 2000, Endocrinology.

[57]  B. Levin.  Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats. , 1999, The American journal of physiology.

[58]  安永徹.  Nutrition related hormonal changes in obese children(肥満児の栄養過多によるホルモン変化について) , 1998 .

[59]  M. Aubert,et al.  Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. , 1993, Endocrinology.

[60]  G. Wolff,et al.  Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) F1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity. , 1988, International journal of obesity.

[61]  M. Greenberg,et al.  An Analysis of the Relationships Among Obesity, Plasma Insulin, and Hepatic Lipogenic Enzymes in "Viable Yellow Obese" Mice (Avy/a)* , 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.